Media Coverage header image

Media Coverage

Advanced Search
  • 12142018
    Tonic-Vice

    These days, cannabidiol, or CBD, which is the non-inebriating compound in marijuana, is being used for pain, anxiety, and as a sleep aid. Also, the FDA recently approved its use for seizures associated with Lennox-Gastaut Syndrome and Dravet Syndrome, which are severe forms of epilepsy. At Quest Diagnostics, one of the biggest drug testing companies in the United States, they don’t offer testing for CBD and it’s not part of any employer drug testing program, says Barry Sample, director of science and technology for employer solutions at the company. Even people who are being drug tested for the DEA are not tested for CBD; in fact, federal employees can only be drug tested for certain predetermined compounds, and CBD isn’t one of them.

  • 12132018
    Becker's Hospital Review Online

    Aetna, a CVS Health business, and Ascension have joined the pilot project applying blockchain technology to improve data quality and reduce administrative costs associated with changes to health care provider demographic data. Humana, MultiPlan, Quest Diagnostics and UnitedHealth Groups Optum and UnitedHealthcare announced the launch of the Synaptic Health Alliance pilot project in April.

  • 12112018
    Harrison Daily Times Online

    Protocol Testing is certified to perform individual, forensic and federally regulated drug and alcohol testing in their offices or at a place of business. Protocol performs urine, hair, nail, and alcohol testing (EtG and Breath) for: pre-employment, post-accident, reasonable suspicion, random, return to duty, follow-up, court ordered, students, probation and workers comp. We are also certified for Paternal DNA Testing. Rick told the group they use a variety of labs used for analysis which include Quest, Labcorp, Expertox, and USDTL.

  • 12112018
    BioWorld MedTech Online

    Although it is crucial to identify tick-borne diseases, including Lyme, early, many tests can be inaccurate or difficult to interpret. Chromacode Inc., of Carlsbad, Calif., is looking to help change that. The company reported the commercial launch of its first multiplex test using its High Definition Polymerase Chain Reaction (HDPCR) technology. Chromacode said the HDPCR Tick-Borne Pathogen (TBP) panel is the only multiplex PCR test that detects nine of the most common tick-borne pathogens in a single test. This past summer, Quest Diagnostics Inc. helped put that in perspective after looking at more than 6 million de-identified laboratory test results over the past seven years and determining that the disease spiked between 2016 and 2017.

  • 12092018
    HealthNewsDigest.com

    Workplace drug testing was jump-started by President Reagan’s 1986 executive order mandating it for federal employees. In 1988, Congress passed The Drug-Free Workplace Act (41 U.S.C. 81). This law requires some Federal contractors and all Federal grantees to agree that they will provide drug-free workplaces as a precondition of receiving a contract or grant from a Federal agency. Over 9.5 million urine drug tests were positive in the U.S. workforce in 2015. The rates increased to 4% of workers tested in 2015 versus 3.9% the year before, per Quest Diagnostics.